Predictive value of contrast enhancement on computed tomography for the responses to oxaliplatin-based chemotherapy with bevacizumab for hepatic metastases from colorectal cancer.
G. Osawa
No relevant relationships to disclose
K. Yoshimatsu
No relevant relationships to disclose
H. Yokomizo
No relevant relationships to disclose
T. Otani
No relevant relationships to disclose
A. Matsumoto
No relevant relationships to disclose
M. Nakayama
No relevant relationships to disclose
Y. Yano
No relevant relationships to disclose
K. Ogawa
No relevant relationships to disclose